β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.
Fiche publication
Date publication
septembre 2016
Journal
BMJ (Clinical research ed.)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves
Tous les auteurs :
Puymirat E, Riant E, Aissoui N, Soria A, Ducrocq G, Coste P, Cottin Y, Aupetit JF, Bonnefoy E, Blanchard D, Cattan S, Steg G, Schiele F, Ferrières J, Juillière Y, Simon T, Danchin N
Lien Pubmed
Résumé
To assess the association between early and prolonged β blocker treatment and mortality after acute myocardial infarction.
Mots clés
Acute Disease, Adrenergic beta-Antagonists, therapeutic use, Aged, Coronary Care Units, Female, Humans, Logistic Models, Male, Middle Aged, Myocardial Infarction, drug therapy, Patient Discharge, statistics & numerical data, Proportional Hazards Models, Prospective Studies, Survival Analysis, Time Factors
Référence
BMJ. 2016 Sep;354:i4801